Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog

The crystal structure of the phosphorylated, activated form of the insulin receptor tyrosine kinase in complex with a peptide substrate and an ATP analog has been determined at 1.9 Å resolution. The activation loop (A‐loop) of the kinase undergoes a major conformational change upon autophosphorylation of Tyr1158, Tyr1162 and Tyr1163 within the loop, resulting in unrestricted access of ATP and protein substrates to the kinase active site. Phosphorylated Tyr1163 (pTyr1163) is the key phosphotyrosine in stabilizing the conformation of the tris‐phosphorylated A‐loop, whereas pTyr1158 is completely solvent‐exposed, suggesting an availability for interaction with downstream signaling proteins. The YMXM‐containing peptide substrate binds as a short anti‐parallel β‐strand to the C‐terminal end of the A‐loop, with the methionine side chains occupying two hydrophobic pockets on the C‐terminal lobe of the kinase. The structure thus reveals the molecular basis for insulin receptor activation via autophosphorylation, and provides insights into tyrosine kinase substrate specificity and the mechanism of phosphotransfer.

[1]  Wayne A. Hendrickson,et al.  Transformations to optimize the superposition of similar structures , 1979 .

[2]  T. Hunter Synthetic peptide substrates for a tyrosine protein kinase. , 1982, The Journal of biological chemistry.

[3]  O. Rosen,et al.  Phosphorylation of exogenous substrates by the insulin receptor-associated protein kinase. , 1983, The Journal of biological chemistry.

[4]  M. Cobb,et al.  Phosphorylation activates the insulin receptor tyrosine protein kinase. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[5]  A. Mildvan,et al.  Mechanistic studies of cAMP-dependent protein kinase action. , 1984, CRC critical reviews in biochemistry.

[6]  Jones Ta,et al.  Diffraction methods for biological macromolecules. Interactive computer graphics: FRODO. , 1985, Methods in enzymology.

[7]  P. H. Seeburg,et al.  Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes , 1985, Nature.

[8]  K. Jarnagin,et al.  The human insulin receptor cDNA: The structural basis for hormone-activated transmembrane signalling , 1985, Cell.

[9]  S. N. Timasheff,et al.  Diffraction methods for biological macromolecules , 1985 .

[10]  W. Rutter,et al.  Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose , 1986, Cell.

[11]  J. Avruch,et al.  Identification of insulin receptor tyrosine residues autophosphorylated in vitro. , 1987, The Journal of biological chemistry.

[12]  C. Kahn,et al.  A cascade of tyrosine autophosphorylation in the beta-subunit activates the phosphotransferase of the insulin receptor. , 1988, The Journal of biological chemistry.

[13]  K. Siddle,et al.  Analysis of insulin-receptor phosphorylation sites in intact cells by two-dimensional phosphopeptide mapping. , 1988, The Biochemical journal.

[14]  T. Hunter,et al.  The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. , 1988, Science.

[15]  W. Kabsch,et al.  Refined crystal structure of the triphosphate conformation of H‐ras p21 at 1.35 A resolution: implications for the mechanism of GTP hydrolysis. , 1990, The EMBO journal.

[16]  J. Zheng,et al.  Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. , 1991, Science.

[17]  C. Kahn,et al.  Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein , 1991, Nature.

[18]  Mike Carson,et al.  RIBBONS 2.0 , 1991 .

[19]  Mutational analysis of conserved residues in the tyrosine kinase domain of the human trk oncogene. , 1991, Oncogene.

[20]  K. Sharp,et al.  Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons , 1991, Proteins.

[21]  M. White,et al.  YMXM motifs of IRS-1 define substrate specificity of the insulin receptor kinase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Tavaré,et al.  Analysis of the order of autophosphorylation of human insulin receptor tyrosines 1158, 1162 and 1163. , 1992, Biochemical and biophysical research communications.

[23]  R. Huber,et al.  Phosphotransferase and substrate binding mechanism of the cAMP‐dependent protein kinase catalytic subunit from porcine heart as deduced from the 2.0 A structure of the complex with Mn2+ adenylyl imidodiphosphate and inhibitor peptide PKI(5‐24). , 1993, The EMBO journal.

[24]  Susan S. Taylor,et al.  2.2 A refined crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MnATP and a peptide inhibitor. , 1993, Acta crystallographica. Section D, Biological crystallography.

[25]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[26]  S V Evans,et al.  SETOR: hardware-lighted three-dimensional solid model representations of macromolecules. , 1993, Journal of molecular graphics.

[27]  M. White,et al.  Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1 , 1993, Molecular and cellular biology.

[28]  R. Kohanski Insulin receptor autophosphorylation. II. Determination of autophosphorylation sites by chemical sequence analysis and identification of the juxtamembrane sites. , 1993, Biochemistry.

[29]  Heidi E. Hamm,et al.  The 2.2 Å crystal structure of transducin-α complexed with GTPγS , 1993, Nature.

[30]  P B Sigler,et al.  The 2.2 A crystal structure of transducin-alpha complexed with GTP gamma S. , 1994, Nature.

[31]  C. Kahn,et al.  Insulin stimulates serine and tyrosine phosphorylation in the juxtamembrane region of the insulin receptor. , 1993, The Journal of biological chemistry.

[32]  K. Siddle,et al.  Mutational analysis of insulin receptor function: consensus and controversy. , 1993, Biochimica et biophysica acta.

[33]  T. Hunter,et al.  Identification of TrkB autophosphorylation sites and evidence that phospholipase C-gamma 1 is a substrate of the TrkB receptor. , 1994, The Journal of biological chemistry.

[34]  C T Roberts,et al.  Essential role of tyrosine residues 1131, 1135, and 1136 of the insulin-like growth factor-I (IGF-I) receptor in IGF-I action. , 1994, Molecular endocrinology.

[35]  J. Navaza,et al.  AMoRe: an automated package for molecular replacement , 1994 .

[36]  C. Kahn,et al.  The insulin signaling system. , 1994, The Journal of biological chemistry.

[37]  R. Hofstra,et al.  A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma , 1994, Nature.

[38]  A. Bardelli,et al.  Tyrosines1234-1235 are critical for activation of the tyrosine kinase encoded by the MET proto-oncogene (HGF receptor). , 1994, Oncogene.

[39]  Susan S. Taylor,et al.  cAMP‐dependent protein kinase: Crystallographic insights into substrate recognition and phosphotransfer , 1994, Protein science : a publication of the Protein Society.

[40]  S. Hubbard,et al.  Crystal structure of the tyrosine kinase domain of the human insulin receptor , 1994, Nature.

[41]  Charis Eng,et al.  Catalytic specificity of protein-tyrosine kinases is critical for selective signalling , 1995, Nature.

[42]  S. Hubbard,et al.  Expression, Characterization, and Crystallization of the Catalytic Core of the Human Insulin Receptor Protein-tyrosine Kinase Domain (*) , 1995, The Journal of Biological Chemistry.

[43]  Susan S. Taylor,et al.  How do protein kinases discriminate between serine/threonine and tyrosine? Structural insights from the insulin receptor protein‐tyrosine kinase , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  A. Ullrich,et al.  Adapter Function of Protein-tyrosine Phosphatase 1D in Insulin Receptor/Insulin Receptor Substrate-1 Interaction (*) , 1995, The Journal of Biological Chemistry.

[45]  J. Olefsky,et al.  Interaction of a GRB-IR Splice Variant (a Human GRB10 Homolog) with the Insulin and Insulin-like Growth Factor I Receptors , 1996, The Journal of Biological Chemistry.

[46]  Hiroto Yamaguchi,et al.  Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation , 1996, Nature.

[47]  Ling-mei Wang,et al.  Interaction of Insulin Receptor Substrate-2 (IRS-2) with the Insulin and Insulin-like Growth Factor I Receptors , 1996, The Journal of Biological Chemistry.

[48]  T. Iwamoto,et al.  The Multiple Endocrine Neoplasia Type 2B Point Mutation Alters Long-term Regulation and Enhances the Transforming Capacity of the Epidermal Growth Factor Receptor (*) , 1996, The Journal of Biological Chemistry.

[49]  P. Jeffrey,et al.  Structural basis of cyclin-dependent kinase activation by phosphorylation , 1996, Nature Structural Biology.

[50]  M. Jaye,et al.  Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction , 1996, Molecular and cellular biology.

[51]  Joseph Schlessinger,et al.  Structure of the FGF Receptor Tyrosine Kinase Domain Reveals a Novel Autoinhibitory Mechanism , 1996, Cell.

[52]  E. Van Obberghen,et al.  Insulin Receptor Substrate-2 Binds to the Insulin Receptor through Its Phosphotyrosine-binding Domain and through a Newly Identified Domain Comprising Amino Acids 591786 (*) , 1996, The Journal of Biological Chemistry.

[53]  E. Van Obberghen,et al.  Insulin receptor substrate-2 binds to the insulin receptor through its phosphotyrosine-binding domain and through a newly identified domain comprising amino acids 591-786. , 1996, The Journal of biological chemistry.

[54]  S. Shoelson,et al.  Human GRB-IRbeta/GRB10. Splice variants of an insulin and growth factor receptor-binding protein with PH and SH2 domains. , 1997, The Journal of biological chemistry.